Breaking News

Home / Unlabelled / Bharat Biotech to conduct intranasal booster dose trials

Bharat Biotech to conduct intranasal booster dose trials

January 29, 2022

 The Drug Controller General of India (DCGI) on Friday allowed Bharat Biotech to conduct intranasal booster dose trials in India.The tests will take place at nine different locations.

ड्रग कंट्रोलर जनरल ऑफ इंडिया (DCGI) ने शुक्रवार को भारत बायोटेक को भारत में इंट्रानैसल बूस्टर डोज ट्रायल करने की अनुमति दे दी।परीक्षण नौ अलग-अलग स्थानों पर होंगे।

No comments

Subscribe to: Post Comments ( Atom )

UGC’s New Draft Rules on Vice-Chancellor Appointments: A Battle Over Federalism and Autonomy

"UGC’s New Draft Rules on Vice-Chancellor Appointments: A Battle Over Federalism and Autonomy" The University Grants Commission (U...